A detailed history of Moisand Fitzgerald Tamayo, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Moisand Fitzgerald Tamayo, LLC holds 1,209 shares of BMY stock, worth $61,562. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,209
Previous 1,209 -0.0%
Holding current value
$61,562
Previous $65,000 23.08%
% of portfolio
0.01%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 18, 2024

SELL
$48.48 - $57.85 $39,899 - $47,610
-823 Reduced 40.5%
1,209 $62,000
Q3 2023

Oct 20, 2023

BUY
$57.89 - $64.73 $29,581 - $33,077
511 Added 33.6%
2,032 $117,000
Q4 2022

Jan 23, 2023

SELL
$68.48 - $81.09 $8,286 - $9,811
-121 Reduced 7.37%
1,521 $0
Q3 2022

Oct 26, 2022

BUY
$0.13 - $76.84 $16 - $9,912
129 Added 8.53%
1,642 $117,000
Q1 2022

Apr 29, 2022

SELL
$61.48 - $73.72 $1,844 - $2,211
-30 Reduced 1.94%
1,513 $110,000
Q3 2021

Nov 01, 2021

SELL
$59.17 - $69.31 $14,792 - $17,327
-250 Reduced 13.94%
1,543 $91,000
Q2 2021

Aug 03, 2021

BUY
$61.91 - $67.42 $9,286 - $10,113
150 Added 9.13%
1,793 $120,000
Q1 2021

May 03, 2021

BUY
$59.34 - $66.74 $5,162 - $5,806
87 Added 5.59%
1,643 $104,000
Q4 2020

Feb 02, 2021

BUY
$57.74 - $65.43 $750 - $850
13 Added 0.84%
1,556 $97,000
Q3 2020

Nov 02, 2020

SELL
$57.43 - $63.64 $976 - $1,081
-17 Reduced 1.09%
1,543 $93,000
Q2 2020

Aug 07, 2020

BUY
$54.82 - $64.09 $931 - $1,089
17 Added 1.1%
1,560 $92,000
Q1 2020

May 13, 2020

BUY
$46.4 - $67.43 $14,105 - $20,498
304 Added 24.54%
1,543 $86,000
Q4 2019

Jan 16, 2020

BUY
$49.21 - $64.19 $59,494 - $77,605
1,209 Added 4030.0%
1,239 $80,000
Q1 2019

May 03, 2019

SELL
$45.12 - $53.8 $22,560 - $26,900
-500 Reduced 94.34%
30 $1,000
Q4 2018

Feb 11, 2019

BUY
$48.76 - $63.23 $24,380 - $31,615
500 Added 1666.67%
530 $28,000
Q3 2017

Nov 03, 2017

BUY
$55.23 - $63.74 $1,656 - $1,912
30
30 $2,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $108B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Moisand Fitzgerald Tamayo, LLC Portfolio

Follow Moisand Fitzgerald Tamayo, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moisand Fitzgerald Tamayo, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moisand Fitzgerald Tamayo, LLC with notifications on news.